Description

Albela (Albendazole) Tablets 400 mg. №3

Ingredients

Active ingredient: Albendazole 400 mg.

Dosage

Dosage: The usual dose is 400 mg as a single dose. Consult a healthcare professional for appropriate dosing.

Indications

Indications: Albendazole is indicated for the treatment of a variety of parasitic worm infestations.

Contraindications

Contraindications: Do not use Albendazole if you are pregnant or breastfeeding. Consult a doctor before use.

Directions

Directions: Take Albendazole as directed by your healthcare provider with a full glass of water.

Scientific Evidence

Albendazole has been extensively studied for its efficacy in treating various parasitic infections. Research published in the International Journal of Infectious Diseases has shown Albendazole to be highly effective in the treatment of neurocysticercosis, a parasitic infection of the central nervous system.

Additional Information

Albendazole works by inhibiting the uptake of glucose by the parasitic worms, leading to their eventual death. It is well-absorbed after oral administration and widely distributed in the body, making it effective against a broad spectrum of parasites.

Pharmacological Effects

Albendazole exerts its pharmacological action by disrupting the microtubule structure in the parasite, leading to immobilization and death of the parasite. This mechanism of action makes Albendazole effective against a wide range of helminths and protozoa.

Clinical Trials and Comparative Effectiveness

Clinical trials have demonstrated the high efficacy of Albendazole in the treatment of parasitic infections, with comparable or superior effectiveness compared to other anthelmintic agents. A study published in the American Journal of Tropical Medicine and Hygiene showed Albendazole to be highly effective in the treatment of soil-transmitted helminth infections.

Overall, Albendazole tablets are a well-established and effective treatment option for various parasitic infections, supported by robust scientific evidence and clinical trials.